Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Century Communities $500 million senior notes offering and concurrent redemption
The high-yield notes are due 2033
GrowthCurve Capital acquisition of PlanHub
We advised GrowthCurve Capital on the transaction
Royalty Pharma $2 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Strive Nasdaq listing and $450 million at-the-market offering
We advised Strive on its Nasdaq listing and offering
Enovix $360 million convertible senior notes and capped call transactions
The 4.75% convertible notes are due 2030
Elevance Health $3 billion senior notes offering
The investment-grade notes are due 2028, 2032, 2036 and 2055
Home Depot $2 billion notes offering
The investment-grade notes are due 2028, 2030 and 2035
Planet Labs PBC $460 million convertible senior notes offering
The 0.5% convertible senior notes are due 2030
Rowan $925 million project financing of three data centers
We advised the agent and arrangers on the facility
Gemini Space Station $450 million IPO
The shares are listed on the Nasdaq Global Select Market